PPD

FEBRUARY 12, 2025

Its important for your clinical research organization (CRO) to continually assess and invest in capabilities that help drive the success of your clinical program. There are three core areas we are strategically addressing this year. They include: 1.

Clinical Supply 69

Clinical Supply Clinical Trials Drug Development Clinical Research 69

The Pharma Data

SEPTEMBER 15, 2020

Find out solutions to mitigate the impact from clinical supply chain risk and discover how to improve dynamic drug supply forecasting strategies. Join this webinar to learn how supply forecasting and interactive response technology can help biotech companies improve supply planning and distribution while reducing cost and risk.

Clinical Supply 52

Clinical Supply Clinical Trials Doctors Clinical Development 52

PPD

SEPTEMBER 6, 2023

Awarded by specific function, in which a CRO could provide single or multiple services, such as site monitoring, data management, post-approval monitoring or clinical supply services, across numerous protocols. Most often done using the vendor’s systems and standard operating procedures (SOP).

Drug Development 98

Drug Development Clinical Trials Drugs Clinical Research 98

Alta Sciences

DECEMBER 14, 2023

Clinical Supply Manufacturing Integration with our manufacturing team, ensuring flexibility and adaptability to meet the evolving needs of your studies throughout your drug development program or study. . - Fully equipped to support all types of IP administration forms.

Compounding Pharmacies 40

Compounding Pharmacies Pharmacy Clinical Pharmacology Clinical Supply 40

The Pharma Data

JANUARY 24, 2021

Sairiyo is advancing the clinical development of its lead drug candidate, Cepharanthine, a repurposed and reformulated naturally derived compound for the potential treatment of cancer, neurological, inflammatory and infectious diseases. Research and development efforts will be led by Dr. Paul Van Slyke.

FDA 52

FDA Drugs Clinical Development Pharmaceutical Companies 52

The Pharma Data

OCTOBER 27, 2020

This collaboration strengthens Novartis’ ongoing commitment to research and partner with other companies to find and develop treatment options for COVID-19 and make them available around the world as fast as possible. During the clinical development stage, Molecular Partners will provide clinical supply.

Therapies 40

Therapies Virus Treatment Clinical Trials 40

BioPharma Drive: Drug Pricing

JUNE 9, 2025

As a gastroenterologist for 35 years, with 25 of those spent in clinical research and seven at Altasciences , I recognize that GLP-1s may be one of the most significant medical advancements of our time—a treatment poised to redefine metabolic disease management. Its new CEO has to figure out what’s next.

Clinical Trials 141

Clinical Trials Drugs Therapies Clinical Supply 141